Kintegral Advisory LLC Has $1.35 Million Stake in Agilent Technologies, Inc. (NYSE:A)

Kintegral Advisory LLC cut its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 32.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 11,569 shares of the medical research company's stock after selling 5,674 shares during the quarter. Kintegral Advisory LLC's holdings in Agilent Technologies were worth $1,353,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Norges Bank purchased a new stake in shares of Agilent Technologies during the fourth quarter worth $456,963,000. Madison Investment Advisors LLC purchased a new stake in shares of Agilent Technologies in the 4th quarter valued at about $94,051,000. GAMMA Investing LLC raised its holdings in shares of Agilent Technologies by 15,648.1% in the 1st quarter. GAMMA Investing LLC now owns 627,247 shares of the medical research company's stock valued at $73,375,000 after acquiring an additional 623,264 shares in the last quarter. Two Sigma Investments LP raised its position in shares of Agilent Technologies by 345.9% during the 4th quarter. Two Sigma Investments LP now owns 769,897 shares of the medical research company's stock valued at $103,428,000 after buying an additional 597,249 shares in the last quarter. Finally, Iron Triangle Partners LP purchased a new stake in Agilent Technologies during the fourth quarter valued at about $80,110,000.

Analysts Set New Price Targets

A number of research firms have weighed in on A. Jefferies Financial Group reduced their target price on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a report on Monday, April 21st. JPMorgan Chase & Co. cut their price target on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a report on Thursday, May 29th. UBS Group dropped their price target on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a report on Thursday, May 29th. Robert W. Baird dropped their price target on Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating on the stock in a research note on Thursday, May 22nd. Finally, Barclays raised their price objective on shares of Agilent Technologies from $115.00 to $125.00 and gave the stock an "equal weight" rating in a report on Tuesday, June 24th. Six equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, Agilent Technologies has an average rating of "Moderate Buy" and an average price target of $140.92.

Agilent Technologies Price Performance

Shares of A stock traded down $2.17 during mid-day trading on Monday, reaching $119.21. The stock had a trading volume of 1,459,663 shares, compared to its average volume of 1,844,968. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55. The business has a 50-day simple moving average of $114.04 and a 200 day simple moving average of $123.03. The company has a market cap of $33.86 billion, a P/E ratio of 29.43, a price-to-earnings-growth ratio of 3.68 and a beta of 1.23. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.26 by $0.05. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. The firm had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.63 billion. During the same quarter in the prior year, the business earned $1.22 EPS. Agilent Technologies's quarterly revenue was up 6.0% compared to the same quarter last year. On average, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.99 annualized dividend and a yield of 0.83%. Agilent Technologies's payout ratio is presently 24.44%.

Insider Transactions at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,508 shares of the stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total transaction of $177,099.52. Following the transaction, the chief executive officer owned 37,448 shares of the company's stock, valued at approximately $4,397,893.12. This represents a 3.87% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.